Brief: Median Technologies Forms Strategic Review Committee To Consider iCRO Separation, US Listing
02/09/2026 17:28
BRIEF-Median Technologies Forms Strategic Review Committee To Consider iCRO Separation, US Listing Sept 2 (Reuters) - Median Technologies SA ALMDT.PA:
MEDIAN TECHNOLOGIES ANNOUNCES FORMATION OF STRATEGIC REVIEW COMMITTEE AND RESEARCH AND DEVELOPMENT COMMITTEE TO UNLOCK INTRINSIC VALUE AND ACCELERATE ITS EYONIS® PAN-CANCER STRATEGY
MEDIAN TECHNOLOGIES - INITIAL FOCUS INCLUDES SEPARATION OF ICRO AND U.S. LISTING OF EYONIS OR COMBINED BUSINESSES
MEDIAN TECHNOLOGIES - STRATEGIC REVIEW TO CONSIDER SEPARATION OF ICRO AND POTENTIAL U.S. LISTING
Source text: ID:nBw320Jzva
Further company coverage: ALMDT.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Median Technologies SA
See all newsBrief: Median Technologies Forms Strategic Review Committee To Consider iCRO Separation, US Listing
France's Median Technologies H1 order backlog rises on demand from biopharmaceutical clients
Brief: Median Technologies H1 Revenue EUR 11.8 Million
Brief: Median Launches Eur 40 Mln Capital Raise To Fund Eyonis Rollout, Extend Runway To H1 2028
Brief: Median Technologies Reports FY Revenue EUR 23.5 Million